Overview

A Clinical Study of Alanyl-Glutamine for Reduction of Post-Myomectomy Adhesions

Status:
Completed
Trial end date:
2016-10-20
Target enrollment:
Participant gender:
Summary
This study evaluates whether L-Alanyl-L-Glutamine can reduce the incidence, extent and severity of adhesions after myomectomy. Half of the participants will receive L-Alanyl-L-Glutamine and the other half of participants will receive a saline placebo at the time of myomectomy.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
AdeTherapeutics Inc.
Temple Therapeutics BV
Collaborator:
University of Saskatchewan